Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s Disease
Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life